FdaApplication
ANDA 215726
Identifiers
- fda_app_no: ANDA215726
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2022-08-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | 300MG/5ML | SUSPENSION;ORAL |
1 product